Trial Profile
Post Marketing Surveillance of Safety and Efficacy for Cholib in Korean Patients Under the "New Drug Re-examination".
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Fenofibrate/simvastatin (Primary)
- Indications Dyslipidaemias
- Focus Adverse reactions
- Sponsors Abbott Laboratories
- 10 Nov 2020 Status changed from recruiting to completed.
- 24 Mar 2016 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 07 Jul 2015 New trial record